| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $683K | +40.0% |
| R&D Expense | $36.9M | +12.2% |
| SG&A Expense | $12.5M | -4.3% |
| Operating Income | -$48.7M | -7.1% |
| Income Tax | $0 | — |
| Net Income | -$45.4M | -9.6% |
| EPS (Basic) | -$0.95 | -2.2% |
| EPS (Diluted) | -$0.95 | -2.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51.5M | +137.7% |
| Short-term Investments | $40.3M | -24.2% |
| Accounts Receivable | $773K | +168.4% |
| Current Assets | $95.1M | +22.8% |
| Total Assets | $97.2M | +19.1% |
| Current Liabilities | $13.4M | +28.6% |
| Total Liabilities | $14.2M | +19.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$37.7M | -22.0% |
| Capital Expenditures | $80K | -86.3% |
| Investing Cash Flow | $13.7M | -62.1% |
| Financing Cash Flow | $53.8M | — |
| Free Cash Flow | -$37.8M | -20.0% |
| Stockholders' Equity |
| $82.9M |
| +18.9% |